$TYME News Article - TYME Announces First Patient
Post# of 31
(Total Views: 122)
Posted On: 09/27/2021 3:55:52 PM
$TYME News Article - TYME Announces First Patient Dosed in Phase II OASIS Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with Metastatic HR+/HER2- Breast Cancer After Treatment with a CDK4/6 Inhibitor https://marketwirenews.com/news-releases/tyme...68490.html
(0)
(0)Tyme Technologies Inc. (TYME) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼